Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm PlcfiledCriticalPhytopharm Plc
Priority to MYPI20021146priorityCriticalpatent/MY134920A/en
Publication of MY134920ApublicationCriticalpatent/MY134920A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
THE INVENTION DISCLOSES THE USE OF SAPOGENIN DERIVATIVES IN THE TREATMENT OF CONGNITIVE DISFUNCTION AND SIMILAR CONDITIONS. METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITION ARE ALSO DISCLOSED.
MYPI200211462002-03-282002-03-285-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
MY134920A
(en)